NON-ALCOHOLIC STEATOHEPATITIS
Clinical trials for NON-ALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug shows promise in fight against scarring liver disease
Disease control OngoingThis large, late-stage study is testing if a weekly injection of semaglutide—a medicine already used for type 2 diabetes—can treat non-alcoholic steatohepatitis (NASH), a serious liver condition. About 1,200 adults with NASH and significant liver scarring will receive either the …
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New scanner could spot fatty liver without MRI
Diagnosis TerminatedThis study aimed to test a new type of ultrasound device for detecting and measuring fat in the liver. Researchers planned to compare the device's accuracy to the current standard method, an MRI scan. The trial was withdrawn before any participants were enrolled.
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC